Overestimation of Low-dose Radiation in Intensity-modulated Radiotherapy with Sliding-window Technique

Overview

Journal Strahlenther Onkol

Specialties Oncology
Radiology

Date 2009 Dec 17

PMID 20013092

Citations 3

Authors

Hilke Vorwerk

Daniela Wagner

Bjorn Seitz

Hans Christiansen

Hendrik A Wolff

Clemens F Hess

Affiliations

Soon will be listed here.

Abstract

Purpose: To analyze different control-system limitations on the measured dose distributions in low-dose regions of simplified intensity fields with an electronic portal imaging device to ascertain the optimal settings for the control-system limitations in the planning system.

Material And Methods: The authors created one field with an "optimal fluence" of intensity 1.0 (full dose) and one field with intensity 0.0 (no dose) in the central part of the field. The influence of different dose rates (DRs) and maximum leaf speeds (LS) on the calculated and measured dose and dose profiles were analyzed.

Results: Good agreement between calculated and measured dose in the case of a field of intensity 1.0 was found. For the field with intensity 0.0, the measured dose was 20-60% lower than the dose calculated by the "actual fluence". The results were found dependent on the DR and LS.

Conclusion: The overestimation in regions of optimal intensity 0.0 by the planning system cannot be resolved by the user. Taking the measured dose in the region of desired intensity 1.0 and other technical limitations (like beam hold interrupts or spikes in the cross and longitudinal profiles) into consideration, the application of an LS of 2.5 cm/s and a DR of 500 MU/min is recommended in order to minimize radiation dose applied to organs at risk, which are located in regions of low intensity, like, for example, the spinal cord.

Citing Articles

Simple proposal for dosimetry with an Elekta iViewGT™ electronic portal imaging device (EPID) using commercial software modules.

Liebich J, Licher J, Scherf C, Kara E, Koch N, Rodel C Strahlenther Onkol. 2011; 187(5):316-21.

PMID: 21544527 DOI: 10.1007/s00066-011-2176-z.

Helical tomotherapy in cervical cancer patients: simultaneous integrated boost concept: technique and acute toxicity.

Marnitz S, Stromberger C, Kawgan-Kagan M, Wlodarczyk W, Jahn U, Schneider A Strahlenther Onkol. 2010; 186(10):572-9.

PMID: 20936458 DOI: 10.1007/s00066-010-2121-6.

A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors.

Jacob V, Bayer W, Astner S, Busch R, Kneschaurek P Strahlenther Onkol. 2010; 186(9):502-10.

PMID: 20803184 DOI: 10.1007/s00066-010-2124-3.

References

Jacob V, Kneschaurek P . A method for improved verification of entire IMRT plans by film dosimetry. Strahlenther Onkol. 2009; 185(1):34-40. DOI: 10.1007/s00066-009-1879-x. View

Studer G, Luetolf U, Glanzmann C . Locoregional failure analysis in head-and-neck cancer patients treated with IMRT. Strahlenther Onkol. 2007; 183(8):417-23. DOI: 10.1007/s00066-007-1663-8. View

Schmidhalter D, Fix M, Niederer P, Mini R, Manser P . Leaf transmission reduction using moving jaws for dynamic MLC IMRT. Med Phys. 2007; 34(9):3674-87. DOI: 10.1118/1.2768864. View

Pasma K, Dirkx M, Kroonwijk M, Visser A, Heijmen B . Dosimetric verification of intensity modulated beams produced with dynamic multileaf collimation using an electronic portal imaging device. Med Phys. 1999; 26(11):2373-8. DOI: 10.1118/1.598752. View

Litzenberg D, Moran J, Fraass B . Incorporation of realistic delivery limitations into dynamic MLC treatment delivery. Med Phys. 2002; 29(5):810-20. DOI: 10.1118/1.1470499. View

Greer P, Vial P, Oliver L, Baldock C . Experimental investigation of the response of an amorphous silicon EPID to intensity modulated radiotherapy beams. Med Phys. 2007; 34(11):4389-98. DOI: 10.1118/1.2789406. View

Pinkawa M, Siluschek J, Gagel B, Piroth M, Demirel C, Asadpour B . Postoperative radiotherapy for prostate cancer : evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy). Strahlenther Onkol. 2007; 183(1):23-9. DOI: 10.1007/s00066-007-1588-2. View

Lips I, Dehnad H, van Gils C, Boeken Kruger A, van der Heide U, van Vulpen M . High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients. Radiat Oncol. 2008; 3:15. PMC: 2430572. DOI: 10.1186/1748-717X-3-15. View

Zhu X, Jursinic P, Grimm D, Lopez F, Rownd J, Gillin M . Evaluation of Kodak EDR2 film for dose verification of intensity modulated radiation therapy delivered by a static multileaf collimator. Med Phys. 2002; 29(8):1687-92. DOI: 10.1118/1.1493781. View

10.

Pai S, Das I, Dempsey J, Lam K, LoSasso T, Olch A . TG-69: radiographic film for megavoltage beam dosimetry. Med Phys. 2007; 34(6):2228-58. DOI: 10.1118/1.2736779. View

11.

Giorgia N, Antonella F, Eugenio V, Alessandro C, Filippo A, Luca C . What is an acceptably smoothed fluence? Dosimetric and delivery considerations for dynamic sliding window IMRT. Radiat Oncol. 2007; 2:42. PMC: 2234418. DOI: 10.1186/1748-717X-2-42. View

12.

Stasi M, Giordanengo S, Cirio R, Boriano A, Bourhaleb F, Cornelius I . D-IMRT verification with a 2D pixel ionization chamber: dosimetric and clinical results in head and neck cancer. Phys Med Biol. 2005; 50(19):4681-94. DOI: 10.1088/0031-9155/50/19/017. View

13.

Warkentin B, Steciw S, Rathee S, Fallone B . Dosimetric IMRT verification with a flat-panel EPID. Med Phys. 2004; 30(12):3143-55. DOI: 10.1118/1.1625440. View

14.

Polat B, Guenther I, Wilbert J, Goebel J, Sweeney R, Flentje M . Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer. Strahlenther Onkol. 2008; 184(12):668-73. DOI: 10.1007/s00066-008-1875-6. View

15.

Olch A . Dosimetric performance of an enhanced dose range radiographic film for intensity-modulated radiation therapy quality assurance. Med Phys. 2002; 29(9):2159-68. DOI: 10.1118/1.1500398. View

16.

Muzik J, Soukup M, Alber M . Comparison of fixed-beam IMRT, helical tomotherapy, and IMPT for selected cases. Med Phys. 2008; 35(4):1580-92. DOI: 10.1118/1.2890085. View

17.

Jang S, Liu H, Mohan R . Underestimation of low-dose radiation in treatment planning of intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008; 71(5):1537-46. DOI: 10.1016/j.ijrobp.2008.04.014. View

18.

Guckenberger M, Flentje M . Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives. Strahlenther Onkol. 2007; 183(2):57-62. DOI: 10.1007/s00066-007-1631-3. View

19.

Low D, Sohn J, Klein E, Markman J, Mutic S, Dempsey J . Characterization of a commercial multileaf collimator used for intensity modulated radiation therapy. Med Phys. 2001; 28(5):752-6. DOI: 10.1118/1.1367863. View

20.

Caglar H, Allen A . Intensity-modulated radiotherapy for head and neck cancer. Clin Adv Hematol Oncol. 2007; 5(6):425-31. View